Peer support program to help patients engage in medication for opioid use disorder
Pilot Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
This study is testing a peer support program to see if it helps people with opioid use disorder stick to their medication treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 12 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | Geisinger Clinic Academic / other |
| Locations | 1 site (Danville, Pennsylvania) |
| Trial ID | NCT06696066 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to assess the feasibility and acceptability of a peer recovery support program designed to enhance patient engagement in medication treatment for opioid use disorder (MOUD). The program, known as PEERS, was developed in collaboration with community and clinical partners specifically for outpatient settings. A total of 12 participants will be recruited from Geisinger outpatient addiction treatment clinics, all of whom will receive the PEERS program. The findings from this pilot will guide future studies aimed at evaluating the program's effectiveness in improving patient retention in MOUD.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have recently initiated medication for opioid use disorder at a Geisinger outpatient addiction treatment clinic.
Not a fit: Patients who have received medication for opioid use disorder at a Geisinger clinic within the past 90 days or are not proficient in English may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve patient retention and engagement in treatment for opioid use disorder.
How similar studies have performed: While peer recovery support programs have shown promise in other contexts, this specific approach is novel and untested in the outpatient MOUD setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult ≥ 18 years of age * Initiated medication for opioid use disorder at a Geisinger outpatient addiction treatment clinic within the past 45 days * Willing to participate in the Peer Recovery Support program * Able and willing to provide consent Exclusion Criteria: * Received medication for opioid use disorder at a Geisinger outpatient addiction treatment clinic in the 90 days prior to the treatment initiation date * Not proficient in English
Where this trial is running
Danville, Pennsylvania
- Geisinger Health — Danville, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Melissa Poulsen, PhD — Geisinger Clinic
- Study coordinator: Project Manager
- Email: PEERS@Geisinger.edu
- Phone: 570-214-5330
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.